Validation Of a Multi-Diagnostic Approach Including Flow Cytometry To Identify Specific Risk Categories Within Low and Intermediate-1 Risk Myelodysplastic Syndromes Within a Prospective Clinical Trial: A Study On Behalf Of The HOVON89 Study Group

Eline M. P. Cremers, Theresia M. Westers, Canan Alhan, Claudia Cali, Heleen A. Visser-Wisselaar, Dana A. Chitu, Marian J. P. L. Stevens-Kroef, Pedro Silva Coelho, Edo Vellenga, Saskia K. Klein, Pierre W. Wijermans, Georgine E. de Greef, Martijn R. Schaafsma, M. Marwijk Kooy, Petra Muus, Gert J. Ossenkoppele, Joop H. Jansen, Arjan A. van de Loosdrecht

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Number of pages2
Issue number21
Publication statusPublished - 15-Nov-2013
Event55th Annual Meeting and expostion of the American Society of Hematology - New Orleans, United States
Duration: 7-Dec-201310-Dec-2013

Cite this